Archive for February 2020

The private university’s board unanimously approved Lynn Perry Wooten as the school’s ninth president. Her term will begin July 1. Read More

Beam Therapeutics raised 80% more than initially planned when it closed its IPO Thursday, just one week after a neighboring company doubled its market launch goal. Read More

Aiven, a Finnish provider of managed cloud service hosting for software infrastructure services, is planning an expansion of its currently limited Boston presence following the closing of a $40 million round of funding. Read More

State marijuana regulators would be empowered to "review, regulate and enforce" the legally-required contracts between marijuana businesses and their host communities under legislation adopted by the House. Read More

The state’s top health care oversight committee is pushing for many of the same policies contained in Gov. Charlie Baker’s health care bill, including a drill down on pharmacy spending and investments on primary care and behavioral health. Read More

A new European drugmaker is opening an office in Boston and setting its sights on a big goal: growing its rare disease revenue from nearly zero to hundreds of millions of dollars annually. Read More

One of Massachusetts’ biggest drugmakers may have two more contests coming down the pipeline over its best-selling drug, but at least one analyst believes the company avoided the “worst case scenario” this week. Read More

Jacquie Moloney said she was inspired to do more after listening to the young Swedish climate activist call on world leaders to take action on climate change last year. Read More

Good morning. Here are the 5 Things You Need to Know in Boston business news, plus the worst business jargon we all use. Read More

At issue in the case is whether subscriptions to online software products are subject to Massachusetts sales tax. Read More